Cost-effectiveness of pertuzumab and trastuzumab as a first-line treatment of HER2-positive metastatic breast cancer in China
@article{APM81088, author = {Hao Wang and Ye Wang and Ruixue Gong and Yuyu Geng and Li Li}, title = {Cost-effectiveness of pertuzumab and trastuzumab as a first-line treatment of HER2-positive metastatic breast cancer in China}, journal = {Annals of Palliative Medicine}, volume = {10}, number = {11}, year = {2021}, keywords = {}, abstract = {}, issn = {2224-5839}, url = {https://apm.amegroups.org/article/view/81088} }